MED Stock Overview
Operates as an investment holding company. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Medco Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₱0.11 |
52 Week High | ₱0.24 |
52 Week Low | ₱0.084 |
Beta | 0.71 |
11 Month Change | -3.57% |
3 Month Change | -22.86% |
1 Year Change | 27.06% |
33 Year Change | -64.00% |
5 Year Change | -73.00% |
Change since IPO | -96.00% |
Recent News & Updates
Recent updates
Shareholder Returns
MED | PH Capital Markets | PH Market | |
---|---|---|---|
7D | -2.7% | -0.6% | 1.5% |
1Y | 27.1% | -12.2% | 15.9% |
Return vs Industry: MED exceeded the PH Capital Markets industry which returned -12.2% over the past year.
Return vs Market: MED exceeded the PH Market which returned 15.9% over the past year.
Price Volatility
MED volatility | |
---|---|
MED Average Weekly Movement | 13.9% |
Capital Markets Industry Average Movement | 7.0% |
Market Average Movement | 5.1% |
10% most volatile stocks in PH Market | 9.9% |
10% least volatile stocks in PH Market | 2.9% |
Stable Share Price: MED's share price has been volatile over the past 3 months compared to the PH market.
Volatility Over Time: MED's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of PH stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1969 | 3 | Dionisio Carpio | www.medco.com.ph |
Medco Holdings, Inc., operates as an investment holding company. Its investment portfolio consists of holdings in companies involved in financial services; and the operation of exhibition halls and conference facilities for trade development. The company was formerly known as Mindanao Exploration & Development Corporation and changed its name to Medco Holdings, Inc. in 1995.
Medco Holdings, Inc. Fundamentals Summary
MED fundamental statistics | |
---|---|
Market cap | ₱379.12m |
Earnings (TTM) | -₱4.19m |
Revenue (TTM) | ₱1.36m |
251.3x
P/S Ratio-81.5x
P/E RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MED income statement (TTM) | |
---|---|
Revenue | ₱1.36m |
Cost of Revenue | ₱449.67k |
Gross Profit | ₱908.20k |
Other Expenses | ₱5.09m |
Earnings | -₱4.19m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0013 |
Gross Margin | 66.88% |
Net Profit Margin | -308.32% |
Debt/Equity Ratio | 58.4% |
How did MED perform over the long term?
See historical performance and comparison